Indokem
- P/E
- Not meaningful: last twelve months’ earnings are mostly a one-off item
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 5.45%
- Debt to Equity
- 0.42
- EPS (TTM)
- ₹0.81
- Book Value
- ₹17.44
- Market Cap
- —
- P/E (TTM)
- Not meaningful: last twelve months’ earnings are mostly a one-off item
- P/B
- 35.54
- ROE
- 1.69%
- Dividend Yield
- 0.00%
- EBITDA
- ₹7.80 Cr
- 52W High
- ₹930.00
- 52W Low
- ₹439.75
- Day Range
- ₹615.00 – ₹631.25
- Volume
- 6,994
Peer Comparison
Commodities › Chemicals › Dyes & Pigments › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Indokem (this company) | ₹619.90 | — | ₹1,740 Cr | 35.54 | 0.00% | 1.69% | 5.45% | ₹174 Cr | ₹2 Cr |
| Median 8 companies | ₹1,559.55 | 57.03 | ₹20,474 Cr | 6.96 | 0.16% | 9.74% | 11.65% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 18
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 14
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 18
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 51
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 46
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
7- Stock is trading at 26.8 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company has a low return on equity of -1.09% over last 3 years.
- Earnings include an other income of Rs.3.18 Cr.
- Working capital days have increased from 37.8 days to 70.5 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 5 | 6 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Neutral
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 46.52
- Neutral
- MACD (12,26,9)
- 0.14
- Bearish
- SMA (50)
- 629.00
- Bearish
- SMA (200)
- 589.40
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | +1.63% |
| 1Y | −5.06% |
| TTM | −4.51% |
Net profit
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Turned to profit |
| 1Y | −33.33% |
| TTM | −57.55% |
Operating cash flow
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | Irregular period |
|---|---|
| 5Y | Irregular period |
| 3Y | +1.10 pp |
| 1Y | −1.53 pp |
| TTM | −2.26 pp |
Revenue by year
| Mar 2006 | ₹68.00 Cr |
|---|---|
| Mar 2007 | ₹68.00 Cr |
| Mar 2008 | ₹67.00 Cr |
| Mar 2009 | ₹69.00 Cr |
| Mar 2010 | ₹52.00 Cr |
| Mar 2011 | ₹28.00 Cr |
| Mar 2023 | ₹161 Cr |
| Mar 2024 | ₹165 Cr |
| Mar 2025 | ₹178 Cr |
| Mar 2026 | ₹169 Cr |
Net profit by year
| Mar 2006 | ₹1.00 Cr |
|---|---|
| Mar 2007 | ₹1.00 Cr |
| Mar 2008 | −₹3.00 Cr |
| Mar 2009 | −₹3.00 Cr |
| Mar 2010 | −₹10.00 Cr |
| Mar 2011 | −₹10.00 Cr |
| Mar 2023 | −₹1.00 Cr |
| Mar 2024 | −₹6.00 Cr |
| Mar 2025 | ₹3.00 Cr |
| Mar 2026 | ₹2.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.16 | 40.34 | 40.26 | 40.04 | 36.98 | 43.29 | 43.4 | 54.43 | 41.57 | 40.3 | 42.02 | 45.5 | 46.63 |
| Expenses | 43.25 | 43.77 | 39.25 | 39.55 | 37.16 | 42.09 | 41.99 | 49.22 | 39.78 | 39.09 | 41.84 | 43.89 | 44.4 |
| Operating Profit | 0.91 | −3.43 | 1.01 | 0.49 | −0.18 | 1.2 | 1.41 | 5.21 | 1.79 | 1.21 | 0.18 | 1.61 | 2.23 |
| OPM % | 2.06% | −8.5% | 2.51% | 1.22% | −0.49% | 2.77% | 3.25% | 9.57% | 4.31% | 3% | 0.43% | 3.54% | 4.78% |
| Other Income | 0.03 | 0.21 | 0.05 | 0.12 | 0.01 | 0.05 | 0.65 | 0.02 | 0.17 | 0.54 | 2.08 | 0.27 | 0.29 |
| Interest | 0.83 | 0.7 | 0.72 | 0.84 | 0.68 | 0.72 | 0.74 | 0.69 | 0.67 | 0.78 | 1.26 | 0.76 | 0.82 |
| Depreciation | 0.51 | 0.74 | 0.48 | 0.78 | 0.54 | 0.55 | 0.59 | 0.56 | 0.59 | 0.55 | 0.6 | 0.61 | 0.62 |
| PBT | −0.4 | −4.66 | −0.14 | −1.01 | −1.39 | −0.02 | 0.73 | 3.98 | 0.7 | 0.42 | 0.4 | 0.51 | 1.08 |
| Tax % | 0% | 0% | 0% | 3.96% | 0% | −50% | 0% | 4.27% | 0% | 2.38% | 0% | 33.33% | 0.93% |
| Net Profit | −0.4 | −4.66 | −0.14 | −1.05 | −1.39 | −0.01 | 0.73 | 3.81 | 0.7 | 0.41 | 0.4 | 0.34 | 1.07 |
| EPS (₹) | −0.16 | −1.91 | −0.05 | −0.37 | −0.49 | 0 | 0.27 | 1.37 | 0.25 | 0.15 | 0.15 | 0.13 | 0.38 |
Profit & Loss
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 68 | 68 | 67 | 69 | 52 | 28 | 161 | 165 | 178 | 169 | 174 |
| Expenses | 66 | 62 | 71 | 65 | 54 | 39 | 158 | 166 | 170 | 165 | 169 |
| Operating Profit | 3 | 7 | −3 | 4 | −2 | −11 | 3 | −1 | 8 | 5 | 5 |
| OPM % | 4.3% | 10% | −5% | 6% | −4.1% | −41% | 1.8% | −0.6% | 4.3% | 2.8% | 3% |
| Other Income | 4 | 1 | 4 | 2 | 0 | 5 | 1 | 0 | 1 | 3 | 3 |
| Interest | 3 | 4 | 0 | 6 | 5 | 0 | 3 | 3 | 3 | 3 | 4 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 |
| PBT | 1 | 1 | −3 | −3 | −10 | −10 | −1 | −6 | 3 | 2 | 2 |
| Tax % | 15% | 15% | 3% | 3% | 0% | 0% | 0% | 1% | 5% | 9% | — |
| Net Profit | 1 | 1 | −3 | −3 | −10 | −10 | −1 | −6 | 3 | 2 | 2 |
| EPS (₹) | 0.48 | 0.53 | −1.84 | −1.27 | −3.94 | −3.89 | −0.54 | −2.22 | 1.14 | 0.67 | 0.81 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 24 | 24 | 24 | 32 | 24 | 28 | 28 | 28 |
| Reserves | 3 | 4 | 2 | −1 | −10 | −10 | 37 | 31 | 34 | 37 |
| Borrowings | 31 | 35 | 36 | 36 | 32 | 21 | 22 | 22 | 22 | 27 |
| Other Liabilities | 34 | 32 | 37 | 40 | 28 | 22 | 39 | 47 | 57 | 54 |
| Total Liabilities | 83 | 85 | 100 | 100 | 74 | 64 | 122 | 128 | 141 | 145 |
| Fixed Assets | 37 | 34 | 62 | 58 | 39 | 33 | 61 | 66 | 65 | 59 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Investments | 7 | 7 | 4 | 4 | 4 | 4 | 0 | 0 | 0 | 1 |
| Other Assets | 39 | 45 | 34 | 38 | 31 | 27 | 61 | 62 | 76 | 85 |
| Total Assets | 83 | 85 | 100 | 100 | 74 | 64 | 122 | 128 | 141 | 145 |
Cash Flow
₹ Cr| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | −5 | 1 | 0 | −10 | −4 | 2 | 4 | 5 | −4 |
| Investing | 0 | 0 | 0 | 0 | 14 | 11 | −4 | −2 | −1 | 3 |
| Financing | −1 | 6 | −1 | 0 | −4 | −3 | 1 | −3 | −3 | 1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 1 | 0 |
| Free Cash Flow | 1 | −5 | 0 | 0 | −10 | −4 | −1 | 3 | 4 | −1 |
| CFO/EBITDA | 49 | −79 | −21 | 2 | 469 | 32 | 83 | −421 | 64 | −88 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 82 | 85 | 71 | 92 | 114 | 117 | 71 | 67 | 78 | 92 |
| Inventory Days | 93 | 141 | 116 | 96 | 79 | 137 | 73 | 84 | 93 | 115 |
| Days Payable | 171 | 164 | 0 | 158 | 144 | 0 | 90 | 109 | 131 | 129 |
| Cash Conversion Cycle | 4 | 62 | 187 | 30 | 48 | 254 | 54 | 43 | 40 | 79 |
| Working Capital Days | 24 | 62 | −21 | −20 | 19 | 13 | 33 | 19 | 23 | 70 |
| ROCE % | — | 10% | −4% | 4% | −4% | −22% | — | −4% | 7% | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Indokem insights
59 extracted metrics across FY06–FY27.
Documents
- 31 Jul 2026
- General announcements 8 Oct 2026
Frequently Asked Questions about Indokem
What does Indokem Ltd do?
Where is Indokem Ltd (INDOKEM) listed?
Which sector does Indokem Ltd belong to?
What is the 52-week high and low of Indokem Ltd?
What is the Return on Equity (ROE) of Indokem Ltd?
Company Information
Incorporated in 1946, Indokem Ltd manufactures and deals in dyes, sizing chemicals auxiliaries and electrical capacitors
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/504092.md for Indokem Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.